India-Korea AI Quantum Healthcare Alliance Signals Medical Industrial Revolution

New Delhi, India — The convergence of artificial intelligence and quantum technology has found a new frontier in healthcare as India and South Korea launched a transformative initiative to industrialize AI-quantum medical devices and diagnostics. This strategic alliance was formalized during the “2025 India-Korea AI & Quantum Medical Device and Healthcare Industrialization Forum,” held at the India International Centre in New Delhi, marking the beginning of an unprecedented bilateral healthcare revolution.

The forum drew over 230 participants, including Indian hospital representatives, medical professionals, and Korean medical technology executives, signaling immense interest in cross-border collaboration. While global healthcare markets continue to witness rapid growth in AI semiconductors and quantum biotechnology, India and Korea are now actively positioning themselves at the core of this transformation.

Chairperson Chung Shin-ja of Global VIGEN Korea, the forum’s primary sponsor, underscored the urgency of moving toward non-contact, predictive diagnostics. “Through AI quantum platforms, we aim to lead industrialization of predictive diagnostic systems, wearable quantum devices, and quantum bio interfaces,” she said, envisioning a healthy, globally connected ecosystem.

The AI semiconductor market, valued at over $70 billion in 2025, is projected to grow to $126 billion by 2030, while the quantum technology market is expected to expand more than sixfold, from 25.9 trillion KRW in 2023 to over 155 trillion KRW in 2030. Complementing these figures, the quantum medical and bio sectors are estimated to reach a combined global valuation exceeding $140 billion by the decade’s end.

The forum’s highlight was the demonstration of the AI-powered quantum medical device, AI MIRACLE PLUS, developed by Global VIGEN Korea. The device is equipped with 25 distinct quantum frequency modes and tailors therapeutic outcomes based on disease type. Clinical trials revealed promising results: arthritis patients reported pain relief after eight sessions using Mode 3, diabetic complications improved under Mode 5, while Mode 18 showed preventive effects for Alzheimer’s and stroke. A randomized clinical study on 101 myocardial infarction patients showed an 86% reduction in recurrence and a 72% psychological recovery rate in the quantum treatment group.

Professor Jeong Seung-phil of Yeungnam University Hospital projected a future where Korea’s AI-quantum systems integrate with India’s traditional natural medicine. “We are looking at the emergence of a new market worth 100 trillion KRW if Indian herbal wisdom aligns with Korean AI and quantum expertise,” he emphasized in a video address.

The forum culminated in signing a landmark memorandum of understanding (MOU) among India’s 120-bed Batra Heart & Multispeciality Hospital, Faidabad, Global VIGEN Korea, and the KSCIM AI Quantum Medical Research Institute. Dr. Punkaj Batra, CMD of Batra Heart & Multispecialty Hospital, was also present. This MOU paves the way for joint device development, clinical research, certification cooperation, market commercialization, and the establishment of an International AI Quantum Medical Society.

The KSCIM Chairperson highlighted the success of quantum-based noninvasive diagnostic systems, which have 99.8% prediction accuracy and 94.9% clinical accuracy. He also announced ongoing research into five new AI quantum frequency modes to tackle chronic diseases ranging from rhinitis to urinary disorders.

Naveen Dubey, forum coordinator, emphasized India’s emerging leadership role in adapting these technologies to its diverse healthcare needs. “This partnership is more than technological—it’s deeply human and inclusive,” he remarked.

Looking forward, VIGEN India CEO Park Sung-gon revealed that the AI Quantum Industrialization Forums will continue—next in India in August 2025 and then in Korea in November—cementing the bilateral commitment to innovation and inclusive health.

By aligning Korea’s tech-intensive health innovations with India’s vast healthcare system and natural medicine tradition, this collaboration aims to set global standards for accessible, precision-driven healthcare. This is not just the birth of a market but the dawn of a new medical era.